JST STRATEGIES LLC (JOCHUM SHORE & TROSSEVIN PC)

Lobbying for GLAXOSMITHKLINE · â€‹Biotechnology pharmaceutical product discovery and development.

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Aug 8, 2025

Lobbying activity 1

Health Issues

Prescription drug pricing issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.